SALT LAKE CITY--(BUSINESS WIRE)--Great Basin Scientific, Inc. (NASDAQ:GBSN), a molecular diagnostic testing company, today reported financial results for the first quarter ended March 31, 2016.
First Quarter 2016 Financial Results and Business Highlights
• Revenue for the first quarter was $731,422, versus $458,730 for the same period in 2015, representing a 59.4% year-over-year increase;
First Quarter 2016 Financial Results and Business Highlights
• Revenue for the first quarter was $731,422, versus $458,730 for the same period in 2015, representing a 59.4% year-over-year increase;
